Wer kennt Worldwide Biotech and Pharmaceutical Company - 500 Beiträge pro Seite

[ipc100euro]

wer kennt diesen wert.

habe heute per e-mail diese empfehlung erhalten:

Worldwide Biotech and Pharmaceutical Company, a biotech company,
engages in the development, manufacture, and marketing of diagnostic reagents.
These diagnostic reagents include hepatitis C viruses, medicines, vaccines,
and gene carriers. The company is based in Sarasota, Florida.

Symbol: WWBP.OB
Price: $2.30
5-10 Day`s Target: $8-10

Buy: Strong
Expectations: 300-500%

When this Stock moves... WATCH OUT! ... This is your chance to get in
while it is still low. WWBP is a high growth issue and should be purchased
by stock traders and those that can afford to make quick money
on these fast moving issues. This is your chance to get your hands
on one of these fast moving stocks and take short term prof1ts.
This stock could reach $10.00 in five to ten trading days.

Big watch in play this Tuesday morning!
Put WWBP on your radar`s now.

[Loserin]

[posting]17.780.570 von ipc100euro am 04.09.05 12:34:55[/posting]habe heute per e-mail diese empfehlung erhalten:



Meine Empfehlung:
ab in die Tonne
Das Thema ist hier durch

[ipc100euro]

sehe es ähnlich

gibt es einen thread, in dem die aktie bereits bespochen wurde. unter stichwortsuche finde ich nichts

[Loserin]

[posting]17.780.605 von ipc100euro am 04.09.05 12:43:56[/posting]Es gab einen Thread heute morgen
Wurde aber gelöscht.

Ich denke da hat sich jemand mit einer gefakten Mailadresse etwas Taschengeld verdienen wollen

[Aufsicht1]

Uups!

Sorry, haben oben einen neuen Thread aufgemacht!
Habe die gleiche Mail wie Du erhalten.

Als reinem Zocker fällt es mir hier schwer
zu wiederstehen....
Mal kuck`n...mir scheint dass die Atie in den USA nicht mehr unter 2 Dollar fallen wird...zumindest in den nächsten Tagen!also evt. einen Verdoppler mitnehmen!?

[Aufsicht1]

Recent Stories

2005-08-25 Close Window
09:05:57


Worldwide Biotech & Pharmaceutical Obtains the China Patent Golden Medal For Its `Intact Hepatitis C Virus (HCV) and Method for Culturing HCV in Vitro by Cell Culture`







XI`AN, China, Aug. 25 /Xinhua-PRNewswire/ -- Worldwide Biotech &
Pharmaceutical Company (OTC Bulletin Board: WWBP) (``WWBP``) has obtained the
China Patent Golden Medal for ``the Intact Hepatitis C Virus (HCV) and Method
for Culturing HCV in Vitro by Cell Culture.``
The project ``The Intact Hepatitis C Virus (HCV) and Method for Culturing
HCV in vitro by Cell Culture`` was awarded the Chinese Patent by China Patent
Bureau on October 23rd, 2002. The patent was then awarded the prestigious
China Patent Golden Medal (Chinese Patent No. 01124001.6) in the 8th China
Patent Assessment organized by both General World Intellectual Property
Organization (WIPO) and the China Patent Office. Importantly, this patent was
recognized by the World Intellectual Property Organization (WIPO), issued as
an outstanding Chinese Patented Invention, and was the highest award issued
for achievements in the biomedical sciences industry over the past 10 years in
China.
``We are highly encouraged with our patent which is recognized by the WIPO
and it is such a great achievement for the whole company. It`s a great
milestone,`` said WenXia Guo, CEO and President of WWBP, ``the success of this
patented invention leads our company to a worldwide market, we will continue
our development and research of new inventions and bring health to every
customer.``
About World Intellectual Property Organization (WIPO)
The World Intellectual Property Organization (WIPO) is an international
organization dedicated to promoting the use and protection of works of the
human spirit. These works -- intellectual property -- are expanding the
bounds of science and technology and enriching the world of the arts. Through
its work, WIPO plays an important role in enhancing the quality and enjoyment
of life, as well as creating real wealth for nations. With headquarters in
Geneva, Switzerland, WIPO is one of the 16 specialized agencies of the United
Nations system of organizations. It administers 23 international treaties
dealing with different aspects of intellectual property protection.
About Worldwide Biotech & Pharmaceutical Company
Worldwide Biotech & Pharmaceutical Co. (``WWBP``) is a hi-tech biotech
company with top-ranking pharmaceutical R&D abilities, Good Manufacturing
Practices (GMP) licensed manufacturing facilities and a well-established
marketing network in China and Southeast Asia. The product range of WWBP
covers Hepatitis C Virus (HCV) products, diagnostic medicines and
Over-The-Counter (OTC) drugs. WWBP currently possesses 35,940 square meters
of land and 5,359 square meters of GMP standard facilities. With strong
pharmaceutical R&D abilities especially in the HCV field, WWBP has been known
as the first biotech company in the world to hold the technology of culturing
intact HCV in vitro by cell culture.
WWBP has achieved a GMP production scale level of 10,000 ml for
concentrated HCV material and 10 grams HCV antigen per month, which is
expected to bring WWBP considerable gross sale revenue each year and greatly
strengthen the company`s R&D on anti-HCV drug screen and HCV human vaccine.
WWBP had successfully reached two Memoriam of Understanding of Merger
Agreements with pharmaceutical companies in China, all of which have scalable
production and well-established sales networks, and the acquiring is expected
to be finished before the end of September 2005. The acquisitions will
strengthen WWBP`s R&D abilities and production scale, as well as extend its
marketing network throughout China and Southeast Asia. WWBP has been working
closely with pharmaceutical research institutes, and has established
connections with both central & local governments.
Safe Harbor
Information in this news release may contain statements about future
expectations, plans, prospects or performance of Worldwide Biotech &
Pharmaceutical Co. that constitute forward-looking statements for purposes of
the safe harbor provisions under the Private Securities Litigation Reform Act
of 1995. The words or phrases "can be," "expects," "may affect," "believed,"
"estimate," "project," and similar words and phrases are intended to identify
such forward-looking statements. Worldwide Biotech & Pharmaceutical Co.
cautions you that any forward-looking information provided by or on behalf of
Worldwide Biotech & Pharmaceutical Co. is not a guarantee of future
performance. None of the information on this website constitutes an offer to
sell securities or investment advice of any kind, and visitors should not base
their investment decisions on information contained in this website. Worldwide
Biotech & Pharmaceutical Co.`s actual results may differ materially from those
anticipated in such forward-looking statements as a result of various
important factors, some of which are beyond Worldwide Biotech & Pharmaceutical
Co.`s control. In addition to those discussed in Worldwide Biotech &
Pharmaceutical Co.`s press releases, public filings, and statements by
Worldwide Biotech & Pharmaceutical Co.`s management, including, but not
limited to, Worldwide Biotech & Pharmaceutical Co.`s estimate of the
sufficiency of its existing capital resources, Worldwide Biotech &
Pharmaceutical Co.`s ability to raise additional capital to fund future
operations, Worldwide Biotech & Pharmaceutical Co.`s ability to repay its
existing indebtedness, the uncertainties involved in estimating market
opportunities and, in identifying contracts which match Worldwide Biotech &
Pharmaceutical Co.`s capability to be awarded contracts. All such
forward-looking statements are current only as of the date on which such
statements were made. Worldwide Biotech & Pharmaceutical Co. does not
undertake any obligation to publicly update any forward-looking statement to
reflect events or circumstances after the date on which any such statement is
made or to reflect the occurrence of unanticipated events.
SOURCE Worldwide Biotech & Pharmaceutical Company


Contact Information:
Ivy Liu of Worldwide Biotech & Pharmaceutical Company, [phone], or mobile, [phone], or [e-mail]

[Aufsicht1]

Quelle:

http://www.otcbbtrader.com

Unter Quote: WWBP eingeben

Unten steht die Medlung

Das Volumen ist in den USA in den letzten Tagen ständig
gestiegen!

Gestern wurden die ersten kleinen Käufe in Deuschland getätigt.

Richtig!
Auch von mir...

Glaube der Meldung mal und lasse mich überraschen!

[Aufsicht1]

Bitte gebt mal eine sachliche Meinung zur Meldung vom 26.08.05 und dem immer höher werdenden Volumen in den USA.

Bitte sachlich !

[Aufsicht1]

17%+>in den USA!

[Aufsicht1]

Kann dazu nur sagen kaufen!

Allein das heutige Volumen in den USA ist Wahnsinn im
Vergleich zu den letzen Monaten!

Mein Motto ist kaufen.
Es hat sich bestätigt dass die USA anziehen werden!

Viel Erfolg bei den anderen Bios!